$ALNA Wedbush analyst Liana Moussatos reiterated a Buy rating on Allena Pharmaceuticals (ALNA) today and set a price target of $6.00. The company’s shares closed last Friday at $1.51. Allena Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $7.00, which is a 373.0% upside from current levels. In a report issued on November 9, H.C. Wainwright also maintained a Buy rating on the stock with a $10.00 price target.
  • 1
1 Like